Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.8190
+0.0384 (4.92%)
At close: Apr 7, 2026, 4:00 PM EDT
0.8190
0.00 (0.00%)
After-hours: Apr 7, 2026, 7:04 PM EDT
Evogene Market Cap
Evogene has a market cap or net worth of $8.12 million as of April 7, 2026. Its market cap has decreased by -12.77% in one year.
Market Cap
8.12M
Enterprise Value
9.43M
1-Year Change
-12.77%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $8.12M, a decrease of -71.03%. That is a compound annual growth rate of -6.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 8.12M | -1.24% |
| Dec 31, 2025 | 8.22M | -36.78% |
| Dec 31, 2024 | 13.00M | -69.10% |
| Dec 31, 2023 | 42.08M | 60.85% |
| Dec 29, 2022 | 26.16M | -63.27% |
| Dec 30, 2021 | 71.23M | -58.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 8.24M |
| Aprea Therapeutics | 8.19M |
| GridAI Technologies | 8.03M |
| TransCode Therapeutics | 7.89M |
| Liminatus Pharma | 7.85M |
| Kiora Pharmaceuticals | 7.66M |
| CollPlant Biotechnologies | 7.63M |
| Creative Medical Technology Holdings | 7.59M |